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Background: Although the association between the apolipoprotein A5 (APOA5) genetic variants and
hypertriglyceridemia has been extensively studied, there have been few studies, particularly in children and
adolescents, on the association between APOA5 genetic variants and obesity or non-high-density lipoprotein
cholesterol (non-HDL-C) levels. The objective of this study was to examine whether APOA5 gene polymorphisms
affect body mass index (BMI) or plasma non-HDL-C levels in Chinese child population.
Methods: This was a case–control study. Single nucleotide polymorphisms (SNPs) were genotyped using Matrix-Assisted
Laser Desorption/Ionization Time of Flight Mass Spectrometry for an association study in 569 obese or overweight
and 194 healthy Chinese children and adolescents.
Results: Genotype distributions for all polymorphisms in both cohorts were in accordance with the Hardy-Weinberg
distribution. The frequencies of the risk alleles in rs662799 and rs651821 SNPs in APOA5 gene were all increased in
obese or overweight patients compared to the controls. After adjusted for age and sex, C carriers in rs662799 had a
1.496-fold [95% confidence interval (CI): 1.074-2.084, P = 0.017] higher risk for developing obesity or overweight than
subjects with TT genotype, while C carriers in rs651821 had a 1.515-fold higher risk than subjects with TT genotype
(95% CI: 1.088-2.100, P = 0.014). Triglyceride (TG) and non-HDL-C concentrations were significantly different among
rs662799 variants and both were higher in carriers of minor allele than in noncarriers for TG (1.64 ± 0.96 vs. 1.33 ±
0.67 mmol/L) (P < 0.001), and for non-HDL-C (3.23 ± 0.92 vs. 3.02 ± 0.80 mmol/L) (P = 0.005), respectively. There was also
a trend towards increased TG and non-high-density lipoprotein cholesterol levels for rs651821 C carriers (P < 0.001 and
P = 0.002, respectively). Furthermore, to confirm the independence of the associations between APOA5 gene and TG or
non-HDL-C levels, multiple linear regression analysis was performed and the relationships were not eliminated by
adjustment for age, sex and BMI.
Conclusions: These findings suggest the TG-raising genetic variants in the APOA5 gene may influence the
susceptibility of the individual to obesity, which may also contribute to an increased risk of high non-HDL-C
levels in Chinese obese children and adolescents.
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Obesity is one of the most complex clinical syndromes
facing children, almost one-third of obese children
remain obese in adulthood and that the risk of obesity
as an adult was close to twice as high for obese children
compared with those who had the normal weight during
the growing period [1]. One of the most deleterious
metabolic disorders of obesity is dyslipidemia, which is
frequently occured and highly atherogenic. Recently,
there is a growing consensus that non-high-density
lipoprotein cholesterol (non-HDL-C), an indicator of
dyslipidemia, appears to be more predictive of persistent
dyslipidemia than total cholesterol (TC), low-density lipo-
protein cholesterol (LDL-C) or high density lipoprotein
cholesterol (HDL-C) for children [2]. In 2011, Expert
Panel on Integrated Guidelines for Cardiovascular Health
and Risk Reduction in Children and Adolescents released
its summary report, which recommends non-HDL-C
as a predictor of cardiovascular disease risk [3]. It
appears that health professionals shall give more atten-
tion on non-HDL-C for a better care of children and
adolescents, especially obese individuals.
In children and adolescents, the effects of environmen-
tal factors such as smoking, drinking and exercise are
considerably weaker than in adults. According to the
previous work the heritability of obesity in infancy is
60-80% and is reported to be 77% in preadolescents
[4,5]. Therefore, it is crucial to investigate the genetic
contribution to obesity and obesity-associated metabolic
abnormalities, permitting screening and preventive
treatment for obese children and adolescents. Many
researchers have discovered multiple commonvariations
that may give rise to genetic susceptibility of common
childhood obesity, such as fat mass and obesity associated
gene, melanocortin 4 receptor gene, glucosamine-6-
phosphate deaminase 2 and so on [6-8]. ApolipoproteinTable 1 Demographic and metabolic characteristics of the stu
Control group (n = 194)
Sex (M/F) 149/45
Age (years) 10.94 ± 2.78
BMI z-scores (−0.27) ± 0.52
SBP (mmHg) 93.9 ± 11.27
DBP (mmHg) 66.35 ± 7.64
TC (mmol/L) 3.80 ± 0.51
TG (mmol/L) 0.77 ± 0.32
HDL-C (mmol/L) 1.50 ± 0.31
LDL-C (mmol/L) 1.94 ± 0.41
non-HDL-C (mmol/L) 2.30 ± 0.43
FPG 4.84 ± 0.48
BMI, Body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure, T
TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipopr
Non-HDL-C, non-high-density lipoprotein cholesterol; FPG, fasting plasma glucose.A5 (APOA5) gene, located on chromosome 11 adjacent to
APOA1/APOC3/APOA4 gene cluster with known func-
tions in the metabolism of plasma lipids [9], also modu-
lates the risk of obesity in a number of studies [10-12].
However, in Chinese children and adolescents, limited
data are available about the effect of APOA5 variants
on childhood obesity and obesity-associated dyslipidemia
such as elevated non-HDL-C levels. To detect additional
common variants associated with obesity and non-
HDL-C in Chinese child population, we conducted this
multicenter study.
Results
The demographic variables and laboratory data of cases
(569 obese or overweight children) and controls (194
healthy individuals) are presented in Table 1. As expected,
there were no differences for the matching criteria of age
and sex between the two cohorts. Compared with data of
control group, obese or overweight group had significantly
elevated body mass index (BMI) z-score, TC, triglyceride
(TG), LDL-C, non-HDL-C levels and lower HDL-C levels
(all P < 0.001).
Overall, rs662799 and rs651821 SNPs were selected
and genotyped in the present study. Genotype distri-
butions for all polymorphisms in both cohorts were in
accordance with the Hardy-Weinberg distribution (data
not shown). The prevalence of rs662799 C allelic variant
in APOA5 gene was significantly elevated in obese or
overweight group compared with control group (30.3%
vs 23.7%, P = 0.013). Meanwhile, a significant elevation
was observed in frequency of risk C allele in rs651821
for obese or overweight group (30.4% versus 24.0% for
controls, P = 0.016). Table 2 shows the genotype distri-
bution of the two polymorphisms in case and control
population. Frequencies of the TT, TC, and CC geno-
types in rs662799 were 48.8%, 41.9% and 9.3% in obesedy participants
Obese or over-weight group (n = 569) P
417/152 0.252
10.76 ± 2.02 0.410
3.19 ± 1.38 <0.001
112.45 ± 14.46 <0.001
68.50 ± 9.09 0.001
4.37 ± 0.92 <0.001
1.49 ± 0.85 <0.001
1.25 ± 0.31 <0.001
2.56 ± 0.71 <0.001
3.14 ± 0.87 <0.001
5.06 ± 0.65 <0.001
C, total cholesterol;
otein cholesterol;
Table 2 Distribution of genotypes for APOA5 SNPs in cases and controls
Gene SNP Genotype Control group Obese or overweight group P
APOA5 rs662799 TT 114 (58.8%) 277 (48.8%) 0.047
TC 68 (35.0%) 238 (41.9%)
CC 12 (6.2%) 53 (9.3%)
APOA5 rs651821 TT 113 (58.2%) 274 (48.2%) 0.048
CT 69 (35.6%) 243 (42.8%)
CC 12 (6.2%) 51 (9.0%)
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trol group, respectively, which were statistically differ-
ent between the two groups (P = 0.047). Additionally,
Frequencies of the TT, CT, and CC genotypes in
rs651821 were also significantly different between obese
or overweight group and control group (P = 0.048).
We then employed logistic regression to test the effect
of the two APOA5 SNPs on the risk of obesity, the
results of which are presented in Table 3. Carriers of the
C allele (CC + TC) in rs662799 had a 1.471-fold higher
risk for developing obesity or overweight [odd ratio
(OR) =1.471, 95% confidence interval (CI): 1.058-2.046,
P = 0.022] than subjects with TT genotype, while carriers of
the C allele (CC+TC) in rs651821 had a 1.486-fold higher
risk than subjects with TT genotype (OR = 1.486, 95% CI:
1.069-2.066, P = 0.018). These associations remained signifi-
cant after controlling for age and sex (rs662799: adjusted
OR 1.496, 95% CI 1.074-2.084, P = 0.017; rs651821: adjusted
OR 1.515, 95% CI 1.088-2.110, P = 0.014).
Next, the association between APOA5 variants and
obesity-related traits in obese or overweight children
were examined. Figure 1 presents the changes in TG
and non-HDL-C levels depending on the rs662799 and
rs651821 polymorphism. Our results provided direct
evidence for an association between the APOA5 poly-
morphism and TG levels in Chinese children and ado-
lescents. Also, non-HDL-C was influenced significantly
by APOA5 gene variants. We noted that the non-HDL-C
in obese or overweight children with non-TT (CC + TC)
genotype was 3.23 ± 0.92 mmol/L, which was elevated
than that in obese children with TT genotype in rs662799
(3.02 ± 0.80 mmol/L) with a significant difference (P =
0.005). There was also a significant trend towards
increased non-HDL-C levels for APOA5 rs651821 CTable 3 OR for obese or overweight associated with minor al
SNP Genotype OR (95% CI)
rs662799 TT 1
CC + TC 1.471 (1.058-2.046)
rs651821 TT 1
CC + TC 1.486 (1.069-2.066)
OR, odds ratio; CI, confidence intervals.
aAdjusted for sex and age.carriers (TT genotype: 3.01 ± 0.80 mmol/L; non-TT
genotype: 3.24 ± 0.92 mmol/L; P = 0.002).
To confirm the independence of the associations
between APOA5 gene polymorphisms and TG or non-
HDL-C levels, multiple linear regression models, using
transformed log-TG as the dependent variable and
including both APOA5 rs662799 and rs651821 variants
and other lipid influencing factors (age, sex, BMI) as the
covariates, were performed in obese or overweight chil-
dren. Carriership for APOA5 rs662799 risk allele was
identified as a significant and independent predictor of
both TG (standardized β-coefficient = 0.184; p < 0.001) and
non-HDL-C variabilities (standardized β-coefficient = 0.179;
p < 0.001). Similarly, carriership for APOA5 rs661821
risk allele was a significant and independent predictor
for both TG (standardized β-coefficient = 0.120; p = 0.004)
and non-HDL-C variabilities (standardized β-coefficient =
0.132; p = 0.002) (Table 4).
Discussion
The rising healthcare costs of obesity and obesity-
associated health problems are sufficient to justify
prevention as daily work of the pediatric clinicians. By
recognizing genetic variants that predispose to obesity,
pediatricians could classify obese children into sub-
groups that might respond to specific diets or physical
activity regimes, drugs or surgeries. In this study, we
selected the most extensively studied SNP in APOA5
gene, tag SNP rs662799 in the promoter region and
another SNP rs651821, located 3 bp upstream from the
predicted start codon of APOA5, which is in linkage
disequilibrium with the much studied rs662799. The
two tightly linked SNPs both show high minor allele
frequencies in Chinese population, our results may belele of each SNP at APOA5 gene
P value Adjusted ORa (95% CI) P value
1
0.022 1.496 (1.074-2.084) 0.017
1
0.018 1.515 (1.088-2.110) 0.014
Figure 1 Lipid profiles according to APOA5 rs662799 and
rs651821 genotypes in obese or overweight children. TG (black
bar), non-HDL-C (gray bar). Results are expressed as mean ± SD
and significant difference: *P < 0.05 non-risk genotypes vs risk
genotypes (TG levels); + P < 0.05 non-risk genotypes vs risk genotypes
(non-HDL-C levels).
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have similar minor allele frequencies.
Our available data supported the hypothesis that the
TG-raising genetic variants in the APOA5 gene may also
have high risks for obesity in Chinese children and ado-
lescents. In consistent with our results, Horvatovich
et al. revealed that APOA5*2 haplotype (containing the
minor alleles of rs662799, rs2072560 and rs2266788)
confers susceptibility to development of obesity in pediatric
patients [13]. Additionally, in Aberle’s study, at baseline,
TT homozygotes had a lower BMI compared to carriers
of the C allele, although without a statistical significanceTable 4 APOA5 variant carriership in multiple linear regressio
obese or overweight subjects
B 95% C
TG
Carrier of APOA5 rs662799 C allele 0.275 0.154
Carrier of APOA5 rs651821 C allele 0.304 0.166
Non-HDL-C
Carrier of APOA5 rs662799 C allele 0.208 0.065
Carrier of APOA5 rs651821 C allele 0.231 0.088
TG, triglyceride; Non-HDL-C, non-high-density lipoprotein cholesterol; CI, confidence
Log-transformed TG was used as the dependent variable; covariates included APOA[14]. Until now much is learned about the biologic
function of APOA5, however, little is known about the
associations between APOA5 variants and body fat
composition. Thus, mechanisms underlying our find-
ings still remain hypothetic, requiring further work to
prove. One speculated mechanism is that the effect of
APOA5 gene variants on the risk of obesity might be
attributed to this locus being in interaction with other
obesity-risk genes, such as APOA1, APOC3 and APOA4
genes [15,16]. Since the APOA1/C3/A4/A5 cluster
occupies a restricted chromosomal region, phenotypic
effects that appear to result from mutations in one
member of the cluster might actually derive from allelic
associations with functional variants in another [17].
Other potential mechanisms could be linked to lipopro-
tein lipase (LPL) activation by the variable effects from
multiple novel APOA5 variants, resulting in varying
degrees of impaired lipolysis [18]. As obesity is a complex,
multifactorial condition for which heritability estimates
vary widely. It might be the case in the association of obes-
ity with APOA5 gene variants, as a result, further studies
are needed to clarify this issue.
Although the association between APOA5 genetic var-
iants and hypertriglyceridemia has been extensively
studied [19-21] and also replicated in our study, there
have been few studies, particularly in children and ado-
lescents, on the association between APOA5 genetic
variants and non-HDL-C levels. Furthermore, the rela-
tionships for TG or non-HDL-C were not eliminated by
adjustment for age, sex and BMI, suggesting that this
genetic factors act independently of age, sex or BMI. In
consistent with our results, Hubacek et al. also sug-
gested that the rs662799 variant in the APOA5 gene
could be a significant genetic determinant for plasma
non-HDL-C levels [22]. So far as we know, there are
scarce studies to provide some mechanism by which
APOA5 gene variants could affect non-HDL-C levels.
It is known that APOA5 protein accelerates plasma
hydrolysis of TG-rich lipoproteins by activation of
plasma LPL [23]. We speculate that abnormalities in
LPL activity could directly lead to delayed hydrolysis ofns with TG or non-HDL-C as the dependent variable in
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metabolites in plasma, such as intermediate density
lipoprotein (IDL), VLDL and chylomicrons, which
resulted in an elevation of plasma non-HDL-C levels.
Certainly, the detailed description of this hypothetic
mechanismis needed for more intensive investigation.
The current study has several limitations that should
be noted. First, the interactions between gene-gene,
gene-environment and even different polymorphic loci
of the same gene may influence the biological effects of
the polymorphisms of the genes. Second, for all the
polymorphisms, the number of the available studies in
some subgroups, such as the control group was small.
Third, due to the cross-sectional nature of the study
design, the causal relationships between gene variants
and clinical disorders can’t be drawn. Thus, we hope to
perform full longitudinal association analyses in larger
samples and more candidate genes in the future pro-
spective studies. Furthermore, studies in the other
populations will be useful to confirm our results.
Conclusions
In conclusion, we herein demonstrated the TG-raising
genetic variants in the APOA5 gene may influence the
susceptibility of the individual to obesity, which may also
contribute to an increased risk of high non-HDL-C
levels in Chinese obese children and adolescents. We be-
lieve that our findings will improve the understanding of
biological functions of APOA5 gene variants.
Methods and procedures
Study population
This case–control study was conducted from 2011to
2012. We totally recruited 569 obese or overweight
patients (“case”) at the age of 7–16 from outpatients
who visited one of the following three medical centers
for their weight problems: (1) Department of Endo-
crinology, Children’s Hospital of Zhejiang University
School of Medicine, Hangzhou, Zhejiang; (2) Department
of Child Health Care, the Affiliated Yuying Children’s
Hospital of Wenzhou Medical University, Wenzhou,
Zhejiang; (3) Department of Child Health Care, Ningbo
Women & Children’s Hospital, Ningbo, Zhejiang. Ac-
cording to the diagnostic criteria developed by the
Working Group for Obesity Task Force in China [24],
the 85th and the 95th percentiles of age- and sex-
specific BMI were used as cut-off points for defining
overweight and obesity, respectively. In addition, we
recruited 194 healthy children (“control”) who were
ascertained at the Department of Child Health Care,
Children Hospital of Zhejiang University School of
Medicine. Exclusion criteria for the controls consisted
of the known presence of diabetes, hypertension, dysli-
pidaemia, other endocrine metabolic or kidney diseasesand the use of medications that altered blood pressure,
glucose, or lipid metabolism.
Informed consent was obtained from the parents, and
approved by the ethics committee of all the aforemen-
tioned three medical centers: the Children Hospital of
Zhejiang University School of Medicine, the Affiliated
Yuying Children’s Hospital of Wenzhou Medical Univer-
sity and Ningbo Women & Children’s Hospital.
Physical parameters
Body height was measured to the nearest 0.1 cm, while
weight was measured to the nearest 0.1 kg. At the time
the measurements were made, the participants were only
their underwear. BMI was calculated as body weight
(kg) divided by the square of body height (m2). Age-
and sex-specific BMI z-scores were used as continuous
dependant variables for each model [25].
Biochemical parameters
Baseline blood samples were obtained early in the mor-
ining after an overnight fast and immediately measured.
Serum TC and TG were determined with an enzymatic
colorimetric. Serum HDL-C and LDL-C were measured
through a direct assay. All biochemical parameters were
measured in a conventional automated analyzer (BECK-
MAN Synchron Clinical System CX4, American). Non-
HDL-C was calculated as TC level minus HDL-C. The
remaining blood samples were stored at −80 degrees
Celsius for SNP genotyping.
SNP genotyping
DNA was isolated from blood samples using Blood
Genomic DNA Miniprep Kit (AxyPrep) according to
the protocol of the manufacturer. All samples were
originally genotyped using an automated platform
MassARRAY (Sequenom, San Diego, CA).
DNA sequence containing the target SNP site was first
amplified by polymerase chain reaction. By using the
SNP specific primers, the products were extended one
base in SNP sites. After applied into the MassARRAY
SpectroCHIP array, the products were crystallized with
matrix in the chip. And then the crystal containing chip
was directed into the mass spectrometer vacuum tube
and excited using an instantaneous nanosecond (10–9 s)
laser. The molecular of matrix absorb the laser radiation,
which resulted in energy accumulation causing crystal
matrix sublimation, DNA molecule desorption and trans-
formation to metastable ions [26].
Statistical analysis
Quantitative variables were expressed as mean ± stand-
ard deviation (SD) and differences between groups were
calculated by Student’s t-test. The chi-square test was
employed to test for deviations of the genotypes from
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ical variables. To determine whether SNP polymorphisms
were independent modulators on the development of
obesity, logistic regression analysis was performed
adjusted for age and sex. We applied ANOVA and the
Studens’s t test to compare crude means across geno-
type groups. A multiple linear regression models pro-
cedure was performed by using transformed log-TG as
the dependent variable, and including carrierships of
APOA5 variants and other influencing factors (age, sex,
BMI) as the covariates. The power calculation was per-
formed using Quanto software (http://hydra.usc.edu/
gxe/). Our study had ≥68.1% to ≥98.5% power (enrol-
ment of 569 cases and 194 controls) to detect Ors of
1.50 to 2.00 for obesity under an additive model, assum-
ing a significance of 0.05, an allele frequency of 0.267,
and overweight or obesity prevalence of 19.9% in 7- to
16- year old Chinese Children [27]. Statistical analysis
was performed using SPSS 17.0 software, and two tailed
P-value <0.05 was considered statistically significant.
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